nVerses Capital’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
Other funds holding AURA
LFCM
nVerses Capital's AURA Position: Q3 2026 in Review
nVerses Capital sold out of Aura Biosciences (AURA) in Q3 2026, closing a stake of 20,798 shares — an estimated $148K sold.
nVerses Capital first reported a position in AURA in Q3 2024 and held it in 2 quarters. The position peaked at $148K in Q2 2026. 154 funds tracked by Wall St. Rank hold AURA as of Q3 2026.
- nVerses Capital reported no remaining Aura Biosciences position as of Q3 2026 after selling out during the quarter.
- nVerses Capital sold 20,798 Aura Biosciences shares in Q3 2026, an estimated $148K.
- nVerses Capital first reported a position in Aura Biosciences in Q3 2024 and held it in 2 quarters.
- nVerses Capital's Aura Biosciences position peaked at $148K in Q2 2026.
- 154 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.
Based on nVerses Capital's 13F filing for Q3 2026.